Sanofi (SNY) Shares Outstanding (Diluted Average) (2009 - 2025)

Sanofi's (SNY) quarterly Shares Outstanding (Diluted Average) came in at $1.4 billion in Q4 2025, up 6.29% year-on-year from $1.3 billion in Q4 2024, and up 52633.8% quarter-over-quarter from $2.7 million in Q2 2025.

Sanofi (SNY) Shares Outstanding (Diluted Average) (2009 - 2025) Analysis & Trends

Sanofi has disclosed Shares Outstanding (Diluted Average) across 17 years of filings, most recently posting $1.4 billion for Q4 2025.

  • Shares Outstanding (Diluted Average) for Q4 2025 came in at $1.4 billion, up 6.29% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.4 billion (up 6.29% YoY), and the FY2025 annual result was $1.4 billion, up 6.29% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $1.4 billion for Q4 2025 at Sanofi, up from $2.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.4 billion in Q4 2021 to a low of $1.8 million in Q2 2024.
  • The 5-year median for Shares Outstanding (Diluted Average) is $642.7 million (2023), against an average of $685.4 million.
  • Across the five-year window, Shares Outstanding (Diluted Average) slumped 67.41% in 2021 and jumped 54.12% in 2025, its largest moves.
  • Sanofi's Shares Outstanding (Diluted Average) stood at $1.4 billion in 2021, then fell by 10.82% to $1.3 billion in 2022, then increased by 5.42% to $1.4 billion in 2023, then slipped by 0.71% to $1.3 billion in 2024, then climbed by 6.29% to $1.4 billion in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $1.4 billion (Q4 2025), $2.7 million (Q2 2025), and $1.3 billion (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 895.90 Mn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 2.45 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 1.77 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 544.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.25 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 5.73 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Sanofi 63.47 Mn -6.87 Bn 9.49 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.43 Bn
Jun 30, 2025 2.71 Mn
Dec 31, 2024 1.34 Bn
Jun 30, 2024 1.76 Mn
Dec 31, 2023 1.35 Bn
Jun 30, 2023 2.97 Mn
Dec 31, 2022 1.28 Bn
Jun 30, 2022 2.71 Mn
Dec 31, 2021 1.44 Bn
Jun 30, 2021 2.65 Mn
Dec 31, 2020 1.50 Bn
Jun 30, 2020 8.13 Mn
Dec 31, 2019 33,206.63
Jun 30, 2019 943,856.84
Dec 31, 2018 1.43 Bn
Jun 30, 2018 1.69 Mn
Dec 31, 2017 1.49 Bn
Jun 30, 2017 5.83 Mn
Dec 31, 2016 3.92 Mn
Jun 30, 2016 1.95 Mn